RE:Shareholder UpdateIt was a good update. Bottom line is that they're waiting on the PEA ( Prelim Economic Assessment).
Nothing can happen without it here now. It's a huge techinal document that formally sets the stage for everything (non Iodine) going fwd.
SGS Canada have dragged their feet..That's an understatement,. but it's nearing final completion now.
Note: All the news flow and behind the scenes work is reliant on the PEA now:it will unlock everything: FDA apps, Sales of final product Canada and US, Plant design, out put, final grade pharma, Industrial grades, bulk sample, financing... Everything!! It's so important.
I spoke with company yesterday ... The PEA is coming soon they expext. So you want facts read and understand this.
If your looking for high momentum micro caps ... Voyageur is not it!
They're building a business in a highly regulated space. So with execution on the items listed above - Post PEA release - you will get appreciation from here IMO with short term liquity
IMO,. If your average is 10 or below you can look to add at the.15 area there will be lots of stock there ( that's break even for buyesof the last financing 15 units ).
Once it chews through that level the whole number may offer more resistance (20). It depends on what milestone they're looking to put away. If the FDA apps have been sent in or announced... If they succeed, the potential approval news for a " device" application can be as little as 90 days ...So know timing ...Or be cautious as IMO I expect the FDA approval news if they get it, to be quite material even perhaps greater much greater than the health Canada approvals were for VM holders.
( I trade in a room with many US penny stock traders and they actually have an " FDA Granted" news scanners that they run for Clip and run day trades ). So VM FDA approval news can quite material ...be cautious not to sell off all of your VM prior to...
VM's Health Canada approval news saw the the stock go from 6 to 39 cents (approx), with liquidity for most of the week prior to heading down to 30 and lower. It held 20 for a while until they needed to finance again.
Prior to FDA granting and sales To the (barite) drug distributors, who will place VM barite products into hospitals and clinics throughout the US ( They don't need a salesforce in the US), there are smaller milestones to be had - you should know them - going fwd I expect the stock to test the $.15 cent area and possibly fail, then re attempt and succeed in material milestones' news.
It may happen this year end iir into Q1 next year.
They have allot coming and VM has paid us well for patience, but the big one in my opinion for 2022 is the getting FDA approcals, then sales open up into that massive market, that currently is supplied by an over charging relentless monopoly provider. VM should easily take some market share ...
My apologies for the typos writing this on my phone. I'm on top on my VM positions. I hope this helps.
Without mentioning names, VM have done allot with much more to do. Obviously not enough for some... If I may be careful where you source your info from ... You can loose out on a position that may be getting ready to move much much higher... But it has to have material milestones' ... VM IMO is a predictable stock. If they knock off the milestones in their update you 'll be happy